Danaher (NYSE:DHR) Shares Rebound 50% From Post-Earnings Drop, Yet $100 Million Delay Puts Recovery to Test

Danaher finished the volatile week at $191.50, up 7.0% from Tuesday’s close. Despite the rebound, the stock remained down 6.0% compared with the previous Friday.

27 July 2026

Danaher Shares Drop 11% After Biotech Division Growth Falls Short of Expectations, Forcing Valuation Adjustment

NEW YORK, July 22, 2026, 05:04 - Danaher shares dropped 11% in early trading, as the company's latest results showed its biotech segment underperformed growth forecasts, prompting a market recalibration of the stock's valuation.

22 July 2026

NYSE:DHR·Stock Market

Danaher (NYSE:DHR) stock drops 14% as bioprocessing gap clouds outlook

Danaher Shares Slide 11% as Valuation Drops Following Biotech Growth Miss

U.S. cash markets were shut when this report was compiled. Danaher Corporation declined 11% in premarket trade on Wednesday after leading losses on the S&P 500 Tuesday.

22 July 2026

NYSE:DHR·Stock Market

Chip Stocks Lead US Equities Higher in After-Hours; Broader Nasdaq Gains Remain Limited

NEW YORK, July 21, 2026, 4:06 p.m. EDT – Wall Street advanced after the close on Tuesday, boosted by a sharp recovery in semiconductor shares, though gains among Nasdaq components stayed narrow as breadth continued to lag.

21 July 2026

NASDAQ:HAS·NASDAQ:MU·NASDAQ:NVDA·NYSE:DHR·NYSE:MMM·Stock Market·US Economy

Danaher (NYSE:DHR) stock drops 14% as bioprocessing gap clouds outlook

U.S. cash markets were open. Delayed data showed Danaher down 13.9% at $173.09 after its quarterly report.

21 July 2026

NYSE:DHR·Stock Market

Danaher stock closes lower ahead of holiday break as traders brace for Fed minutes, GDP and PCE

Danaher Corp dropped 1.1% to close at $212.58 on Friday, chalking up a second day in the red, even as the S&P 500 and Dow posted modest gains. The stock remains roughly 12% under its Jan. 22, 52-week high. Thermo Fisher declined as well; Abbott moved up, while Medtronic slipped.

15 February 2026

Federal Reserve·NYSE:DHR·Stock Market

Danaher stock price dips late Friday; what DHR traders watch after CPI and into the Presidents Day break

Danaher Corporation shares slipped around 1.2% to $212.58 in Friday’s after-hours trade, having bounced between $210.80 and $218.48 during the session. Volume came in at roughly 5.3 million shares.

14 February 2026

Earnings Reports·NYSE:DHR·Stock Market

Danaher stock price jumps 2% to $223 as DHR snaps losing streak in late trade

Danaher’s stock jumped about 2.1% to finish Monday at $223.42, holding its ground in after-hours trading. The shares fluctuated between $216.90 and $224.00 during the session, with around 4.7 million changing hands, ending a four-day losing streak. The broader market also gained, as the S&P 500 climbed 0.54% and the Dow Jones Industrial Average rose 1.05%.

2 February 2026

Earnings Reports·NYSE:DHR·Stock Market

Danaher stock steadies near $220 after earnings slide as 2026 outlook comes into focus

Danaher shares ticked up 0.1% to $219.83 Friday afternoon, bouncing back after a sharp slide earlier this week. The stock swung between $217.60 and $221.00 throughout the session.

30 January 2026

Earnings Reports·NYSE:A·NYSE:DHR·NYSE:TMO·NYSE:WAT·Stock Market

Danaher stock slides again after outlook: what DHR investors are watching next

Danaher shares fell 2.2% to $219.49 on Thursday afternoon, pressured all session following a weak open. The stock swung between $218.79 and $225.43, with about 3.45 million shares traded.

29 January 2026

Earnings Reports·NYSE:DHR·Stock Market

Danaher (DHR) stock slides nearly 5% after earnings beat as 2026 outlook lands “in line”

Shares of Danaher slipped 4.8% to close Wednesday at $224.54, following the release of its 2026 profit outlook that aligned closely with Wall Street expectations.

29 January 2026

Earnings Reports·NYSE:DHR·Stock Market

Thermo Fisher stock pulls back from near-$630: what to know before earnings

Shares of Thermo Fisher Scientific Inc slipped Friday, surrendering early gains after hitting just below $630. The stock finished at $618.72, down 0.95%, with trading ranging from $618.71 to $629.73, per Investing.com data.

17 January 2026

Earnings Reports·NYSE:A·NYSE:DHR·NYSE:TMO·Stock Market

Thermo Fisher (TMO) stock jumps as Stifel lifts target to $700; earnings next

Thermo Fisher Scientific Inc shares climbed roughly 2% on Friday following a price target boost from Stifel, which called for a “solid year” ahead as biopharma demand picked up. The stock ended the day up $12.45, closing at $618.86.

10 January 2026

Earnings Reports·NYSE:A·NYSE:DHR·NYSE:TMO·Stock Market

Danaher stock slips as analysts lift targets ahead of JPM Healthcare Conference, earnings

Danaher Corporation stock slipped on Wednesday, closing at $235.60, down 0.42%. The shares were last up 0.16% in extended trading.

8 January 2026

Earnings Reports·NYSE:DHR·Stock Market

Danaher stock beats Wall Street dip as investors eye Fed minutes and Jan. 28 earnings

Danaher Corp shares were last up about 0.1% at $230.63 on Monday, after trading between $229.26 and $231.77 during the session.

30 December 2025

Earnings Reports·Federal Reserve·NYSE:DHR·Stock Market

Danaher (DHR) Stock After Hours on Dec. 24, 2025: What Happened After the Early Close — and What to Know Before the Next Market Open

Danaher Corporation ended Wednesday, Dec. 24, 2025 on a quiet note in a holiday-shortened session, then drifted only slightly in after-hours trading. With U.S. markets closed on Christmas Day and set to reopen Friday, Dec. 26, the key “overnight” story for Danaher is less about a dramatic after-hours move — and more about calendar-driven factors and a handful of headline items investors may see circulating before the next open. New York Stock Exchange+1

25 December 2025

NYSE:DHR·Stock Market

Danaher Stock (DHR) News Today: BofA Lifts Price Target to $265, Wells Fargo to $240 as 2026 Normalization Comes Into Focus

Danaher Corporation is back in the spotlight on Monday, December 15, 2025, after two fresh Wall Street updates pushed Danaher stock back into the “what’s next” conversation for life-science and diagnostics investors. In afternoon trading, DHR hovered around $227 per share, modestly higher on the day.

15 December 2025

NYSE:DHR·Stock Market

Danaher (DHR) Stock: What to Know Before the US Market Opens on Monday, Dec. 15, 2025

Danaher Corporation heads into the Monday, Dec. 15 US stock market open after a choppy finish to last week. Shares closed Friday, Dec. 12 at $226.33, down 2.60% on the day, with trading volume reported above its 50‑day average—an indication that investors were actively repositioning into the weekend. MarketWatch

14 December 2025

NYSE:DHR·Stock Market·US Economy

Danaher Stock DHR: What Happened This Week, Latest News, and the Week-Ahead Outlook

Danaher Corporation stock finished the week with a sharp Friday pullback after a strong midweek rebound—leaving investors with the same big question heading into next week: was this just normal volatility in a high-quality healthcare name, or a sign the market is repricing the 2026 recovery story?

13 December 2025

NYSE:DHR·Stock Market·Weekly Outlook

Danaher Corporation Stock (DHR) Today: Latest News, Analyst Forecasts, and What Investors Are Watching on Dec. 12, 2025

Danaher Corporation is trading near the $231 level on Friday, Dec. 12, 2025, as fresh valuation takes, analyst coverage, and institutional positioning keep the life-sciences and diagnostics leader on investors’ screens. Here’s a complete roundup of today’s key developments, the newest forecasts, and the catalysts that could shape DHR’s next move.

12 December 2025

NYSE:DHR·Stock Market

1 2 Next

Danaher Shares Drop 11% After Biotech Division Growth Falls Short of Expectations, Forcing Valuation Adjustment

Danaher Shares Slide 11% as Valuation Drops Following Biotech Growth Miss

Chip Stocks Lead US Equities Higher in After-Hours; Broader Nasdaq Gains Remain Limited

Danaher (NYSE:DHR) stock drops 14% as bioprocessing gap clouds outlook

Danaher stock closes lower ahead of holiday break as traders brace for Fed minutes, GDP and PCE

Danaher stock price dips late Friday; what DHR traders watch after CPI and into the Presidents Day break

Danaher stock price jumps 2% to $223 as DHR snaps losing streak in late trade

Danaher stock steadies near $220 after earnings slide as 2026 outlook comes into focus

Danaher stock slides again after outlook: what DHR investors are watching next

Danaher (DHR) stock slides nearly 5% after earnings beat as 2026 outlook lands “in line”

Thermo Fisher stock pulls back from near-$630: what to know before earnings

Thermo Fisher (TMO) stock jumps as Stifel lifts target to $700; earnings next

Danaher stock slips as analysts lift targets ahead of JPM Healthcare Conference, earnings

Danaher stock beats Wall Street dip as investors eye Fed minutes and Jan. 28 earnings

Danaher (DHR) Stock After Hours on Dec. 24, 2025: What Happened After the Early Close — and What to Know Before the Next Market Open

Danaher Stock (DHR) News Today: BofA Lifts Price Target to $265, Wells Fargo to $240 as 2026 Normalization Comes Into Focus

Danaher (DHR) Stock: What to Know Before the US Market Opens on Monday, Dec. 15, 2025

Danaher Stock DHR: What Happened This Week, Latest News, and the Week-Ahead Outlook

Danaher Corporation Stock (DHR) Today: Latest News, Analyst Forecasts, and What Investors Are Watching on Dec. 12, 2025

TechStock² Updates

N-able Shares Climb 9.1% After $95 Million Buyback Equals 11.7% of Market Value

SharonAI Shares Drop 4.2% After Nvidia Halts Financing, Leaving $4.88 Billion Deal in Limbo

Workday Shares Gain 2.9% as AI Agents Account for Quarter of New Contract Value

Veeva Shares Maintain 14.8% Earnings Surge; Revenue Hits $928 Million

Cytokinetics Shares Drop 5% Even as Company Delivers First Positive Phase 3 Results in Non-Obstructive HCM

US Stock Market Today Updates

Asia Stock Market Today Updates

UK Stock Market Today Updates

Australia Stock Market Today Updates

Top Stock Picks

NVIDIA

Meta Platforms

Alphabet

Amazon

Microsoft

Key Events Today

Warsh at Jackson Hole

Michigan sentiment

Chicago PMI

Investment Disclaimer